In Vitro Evaluation of the Drug Interaction Potential of Doravirine
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Evaluation of the Drug Interaction Potential of Doravirine
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 63, Issue 4, Pages -
Publisher
American Society for Microbiology
Online
2019-02-12
DOI
10.1128/aac.02492-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Pharmacokinetics of Doravirine and Exposure-Response Analysis in Individuals with HIV-1
- (2019) Ka Lai Yee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects
- (2018) Sauzanne G. Khalilieh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans
- (2018) Rosa I. Sanchez et al. XENOBIOTICA
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- (2018) Jean-Michel Molina et al. Lancet HIV
- Can BSEP Inhibition Testing In Drug Discovery And Development Reduce Liver Injury Risk? - An International Transporter Consortium Perspective
- (2018) J Gerry Kenna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI
- (2017) Rosa Chan et al. TOXICOLOGICAL SCIENCES
- Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection
- (2016) Eleanor E. Friedman et al. AIDS
- Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations
- (2016) Meizhen Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Results of a doravirine-atorvastatin drug-drug interaction study
- (2016) Sauzanne Khalilieh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir
- (2016) Matt S. Anderson et al. CLINICAL PHARMACOKINETICS
- Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
- (2016) Julia L. Marcus et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1
- (2016) Jayabharathi Vaidyanathan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function
- (2015) Ágnes Telbisz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity
- (2014) Rujuta A Bam et al. ANTIVIRAL THERAPY
- Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects
- (2014) Matt S Anderson et al. ANTIVIRAL THERAPY
- Raltegravir Has a Low Propensity To Cause Clinical Drug Interactions through Inhibition of Major Drug Transporters: anIn VitroEvaluation
- (2013) Matthew L. Rizk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
- (2011) G. Guaraldi et al. CLINICAL INFECTIOUS DISEASES
- Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design
- (2010) M L Reitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease
- (2010) E. Monteagudo et al. XENOBIOTICA
- Bile acid transporters
- (2009) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- The Multiple Depletion Curves Method Provides Accurate Estimates of Intrinsic Clearance (CLint), Maximum Velocity of the Metabolic Reaction (Vmax), and Michaelis Constant (Km): Accuracy and Robustness Evaluated through Experimental Data and Monte Carlo Simulations
- (2008) E. Sjogren et al. DRUG METABOLISM AND DISPOSITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation